PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,713,260 | -25.5% | 1,792,114 | 0.0% | 4.15% | +1.1% |
| Q2 2023 | $6,326,162 | +14.2% | 1,792,114 | 0.0% | 4.10% | +106.9% |
| Q1 2023 | $5,537,632 | -27.0% | 1,792,114 | 0.0% | 1.98% | -37.7% |
| Q4 2022 | $7,580,642 | +78.5% | 1,792,114 | 0.0% | 3.19% | +100.3% |
| Q3 2022 | $4,247,000 | -16.9% | 1,792,114 | 0.0% | 1.59% | -25.9% |
| Q2 2022 | $5,108,000 | -1.0% | 1,792,114 | 0.0% | 2.15% | +17.1% |
| Q1 2022 | $5,161,000 | – | 1,792,114 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |